Honghai Li

Title: Innovations of Honghai Li in Snake Venom Detection

Introduction

Honghai Li is a notable inventor based in Shandong, China. He has made significant contributions to the field of snake venom detection through his innovative research and patents. His work focuses on developing methods to identify and quantify snake venom-like thrombin, which is crucial for medical and pharmaceutical applications.

Latest Patents

Honghai Li holds a patent for a marker polypeptide of Bothrops atrox-like thrombin and a method for detecting the species source and content of snake venom-like thrombin. This patent is particularly important as it provides a specific amino acid sequence, EAYNGLPAK (SEQ ID NO:1), which can be utilized to detect the species source and content of snake venom-like thrombin in various samples. The implications of this invention are significant, as it helps in characterizing the species source and content of snake venom-like thrombin, thereby filling a critical gap in the quality standards of snake venom.

Career Highlights

Throughout his career, Honghai Li has worked with esteemed organizations such as the Shandong Institute for Food and Drug Control and Penglai Nuokang Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the field of pharmacology and toxicology.

Collaborations

Honghai Li has collaborated with notable colleagues, including Ruiqing Xian and Baojian Hang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the scientific community.

Conclusion

Honghai Li's innovative contributions to snake venom detection highlight the importance of research in this specialized field. His patent and collaborations demonstrate his commitment to advancing scientific knowledge and improving safety standards in medical applications.